RRN3
Basic information
Region (hg38): 16:15060033-15094311
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (96 variants)
- not_provided (2 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the RRN3 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000018427.5. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 2 | |||||
| missense | 92 | 96 | ||||
| nonsense | 0 | |||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 0 | |||||
| Total | 0 | 0 | 92 | 6 | 0 |
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| RRN3 | protein_coding | protein_coding | ENST00000198767 | 18 | 34296 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 0.0000162 | 1.00 | 125712 | 0 | 36 | 125748 | 0.000143 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | -0.770 | 381 | 341 | 1.12 | 0.0000179 | 4282 |
| Missense in Polyphen | 135 | 135.44 | 0.99672 | 1796 | ||
| Synonymous | -2.32 | 159 | 126 | 1.26 | 0.00000685 | 1194 |
| Loss of Function | 3.15 | 14 | 33.8 | 0.414 | 0.00000166 | 438 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.000277 | 0.000271 |
| Ashkenazi Jewish | 0.000147 | 0.0000992 |
| East Asian | 0.000166 | 0.000163 |
| Finnish | 0.000278 | 0.000277 |
| European (Non-Finnish) | 0.000175 | 0.000167 |
| Middle Eastern | 0.000166 | 0.000163 |
| South Asian | 0.0000327 | 0.0000327 |
| Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Required for efficient transcription initiation by RNA polymerase I. Required for the formation of the competent preinitiation complex (PIC). Dissociates from pol I as a consequence of transcription. In vitro, cannot activate transcription in a subsequent transcription reaction (By similarity). {ECO:0000250, ECO:0000269|PubMed:10758157, ECO:0000269|PubMed:11250903, ECO:0000269|PubMed:11265758, ECO:0000269|PubMed:15805466}.;
- Pathway
- Gene expression (Transcription);RNA Polymerase I Promoter Clearance;RNA Polymerase I Transcription;RNA Polymerase I Transcription Initiation;RNA Polymerase I Promoter Escape;mTOR signaling pathway
(Consensus)
Recessive Scores
- pRec
- 0.134
Intolerance Scores
- loftool
- 0.768
- rvis_EVS
- 0.38
- rvis_percentile_EVS
- 75.58
Haploinsufficiency Scores
- pHI
- 0.0992
- hipred
- Y
- hipred_score
- 0.648
- ghis
- 0.554
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.953
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Rrn3
- Phenotype
- cellular phenotype; homeostasis/metabolism phenotype; growth/size/body region phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); embryo phenotype;
Gene ontology
- Biological process
- RNA polymerase I preinitiation complex assembly;in utero embryonic development;transcription initiation from RNA polymerase I promoter;nucleolus organization;cytoplasm organization;cell population proliferation;positive regulation of neuron projection development;ribosome biogenesis;positive regulation of transcription, DNA-templated;homeostasis of number of cells;negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator;regulation of DNA-templated transcription, initiation
- Cellular component
- nucleus;nucleoplasm;nucleolus
- Molecular function
- RNA polymerase I core binding;RNA polymerase I CORE element sequence-specific DNA binding;RNA polymerase I general transcription initiation factor activity